|
Communicating statistical concerns to the FDA
|
|
3
|
400
|
March 11, 2024
|
|
Retrospective discussion on the ALS drug, RELYVRIO
|
|
0
|
281
|
March 10, 2024
|
|
Tresholds in bayesian designs
|
|
0
|
142
|
March 6, 2024
|
|
Random effects in mixed-effect multivariable logistic regression models
|
|
0
|
237
|
March 5, 2024
|
|
RMS Ordinal Logistic Regression
|
|
34
|
14052
|
March 3, 2024
|
|
Statistical Parameter Mapping
|
|
4
|
276
|
February 28, 2024
|
|
Percentage as a measure of a predictor variable
|
|
7
|
453
|
February 27, 2024
|
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
375
|
February 23, 2024
|
|
Evaluating seizures in open-label studies
|
|
5
|
267
|
February 20, 2024
|
|
Prior design in a bayesian re-analysis of an RCT
|
|
1
|
275
|
February 19, 2024
|
|
Problems with NNT
|
|
36
|
33149
|
February 19, 2024
|
|
Assessing correlation/surrogacy between 2 estimated treatment effects
|
|
9
|
482
|
February 17, 2024
|
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
2967
|
February 16, 2024
|
|
RCT: protocol deviation and implications for analysis
|
|
6
|
368
|
February 16, 2024
|
|
Some thoughts on uniform prior probabilities when estimating P values and confidence intervals
|
|
15
|
534
|
February 11, 2024
|
|
AIC vs qq-plot for deciding the best model
|
|
2
|
335
|
February 11, 2024
|
|
Handling missing continuous data due to death
|
|
7
|
400
|
February 8, 2024
|
|
Time to pre-randomization monthly seizure count
|
|
1
|
197
|
February 8, 2024
|
|
RMS Modeling Longitudinal Responses
|
|
45
|
17043
|
February 8, 2024
|
|
Sample Size calculation - "subgroup hypothesis", Guidance needed
|
|
2
|
412
|
February 4, 2024
|
|
ITT analysis population - RCT
|
|
6
|
820
|
February 3, 2024
|
|
Bayesian Regression Modeling Strategies
|
|
89
|
8153
|
February 3, 2024
|
|
Is there a way to display the reference category(ies) in a regression output in rms?
|
|
6
|
398
|
February 2, 2024
|
|
Recommendations for the development of prediction models for small sample studies (rare disease/low outcome)
|
|
1
|
309
|
February 1, 2024
|
|
Does subtracting/or not, the mean-rank in Wilcoxon-Mann-Whitney make any difference?
|
|
4
|
315
|
February 1, 2024
|
|
Creating a Nomogram with Multiply Imputed Datasets
|
|
1
|
349
|
January 31, 2024
|
|
Prevalence and probability
|
|
4
|
6350
|
January 29, 2024
|
|
I'd be interested in any views on this attempt to predict COVID-19 hospitalizations using SARS-CoV-2 concentrations in wastewater (sewage)
|
|
8
|
888
|
January 13, 2024
|
|
Does BI-RADS imply agreed preference regarding treatment harm?
|
|
7
|
292
|
January 25, 2024
|
|
Practicalities of using Markov Longitudinal Ordinal Models in Cardiovascular Outcome Trials
|
|
5
|
513
|
January 25, 2024
|